Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard S Gold

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Clinical Microbiology|February 5, 2010
Direct detection of methicillin resistance in Staphylococcus aureus in blood culture broth by use of a penicillin binding protein 2a latex agglutination testQinfang Qian, Lata Venkataraman, James E Kirby, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm RiskCatherine Li, Nicholas J Mercuro, Ryan W Chapin, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patientsKenneth M Wener, Vered Schechner, Howard S Gold, et al.
Emerging Infectious Diseases|April 14, 2004
Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogensMitchell J Schwaber, Sara E Cosgrove, Howard S Gold, et al.
Emerging Infectious Diseases|January 14, 2004
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patientsStephen G Weber, Howard S Gold, David C Hooper, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter speciesMitchell J Schwaber, Camilla S Graham, Bruce E Sands, et al.
Infection Control and Hospital Epidemiology|August 2, 2018
Perioperative antimicrobial prophylaxis and prevention of hepatobiliary surgical site infectionsConor M Stack, Howard S Gold, Sharon B Wright, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 27, 2019
Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropeniaMatthew S L Lee, Bharat Ramakrishna, Alan C Moss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolidSibtain Rahim, Satish K Pillai, Howard S Gold, et al.
Annals of the American Thoracic Society|December 15, 2015
More than Meets the Eye. A 23-Year-Old Woman with Rapidly Progressive Respiratory Failure, Mucositis, and RashRitika S Parris, Gabriel M Cohen, P Alexander Leahey, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|February 5, 2010
Direct detection of methicillin resistance in Staphylococcus aureus in blood culture broth by use of a penicillin binding protein 2a latex agglutination testQinfang Qian, Lata Venkataraman, James E Kirby, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm RiskCatherine Li, Nicholas J Mercuro, Ryan W Chapin, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patientsKenneth M Wener, Vered Schechner, Howard S Gold, et al.
Emerging Infectious Diseases|April 14, 2004
Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogensMitchell J Schwaber, Sara E Cosgrove, Howard S Gold, et al.
Emerging Infectious Diseases|January 14, 2004
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patientsStephen G Weber, Howard S Gold, David C Hooper, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter speciesMitchell J Schwaber, Camilla S Graham, Bruce E Sands, et al.
Infection Control and Hospital Epidemiology|August 2, 2018
Perioperative antimicrobial prophylaxis and prevention of hepatobiliary surgical site infectionsConor M Stack, Howard S Gold, Sharon B Wright, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 27, 2019
Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropeniaMatthew S L Lee, Bharat Ramakrishna, Alan C Moss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolidSibtain Rahim, Satish K Pillai, Howard S Gold, et al.
Annals of the American Thoracic Society|December 15, 2015
More than Meets the Eye. A 23-Year-Old Woman with Rapidly Progressive Respiratory Failure, Mucositis, and RashRitika S Parris, Gabriel M Cohen, P Alexander Leahey, et al.
Pageof 5